Sun Pharmaceutical Industries informs about press release

30 Oct 2023 Evaluate
Sun Pharmaceutical Industries has enclosed Press Release titled: ‘Sun Pharma and Zydus sign licensing agreement for co-marketing of Desidustat, a critical treatment for chronic kidney disease patients in India’. This submission is being made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1631.65 -2.75 (-0.17%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×